| Secondary |
| Drug Use For Unknown Indication |
19.2% |
| Herpes Zoster |
7.5% |
| Pyelonephritis |
7.5% |
| Osteoporosis |
6.7% |
| Product Used For Unknown Indication |
6.7% |
| Cystitis |
5.8% |
| Influenza |
5.0% |
| Phantom Pain |
5.0% |
| Rectal Cancer Metastatic |
5.0% |
| Back Pain |
3.3% |
| Hypertension |
3.3% |
| Pain In Extremity |
3.3% |
| Prophylaxis |
3.3% |
| Pyrexia |
3.3% |
| Breast Cancer |
2.5% |
| Cerebral Oedema Management |
2.5% |
| Insomnia |
2.5% |
| Joint Sprain |
2.5% |
| Myalgia |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
|
| Agranulocytosis |
10.0% |
| Altered State Of Consciousness |
10.0% |
| Stevens-johnson Syndrome |
10.0% |
| Duodenal Perforation |
6.7% |
| Haemoglobin Decreased |
6.7% |
| Urethral Haemorrhage |
6.7% |
| Vomiting |
6.7% |
| White Blood Cell Count Increased |
6.7% |
| Aphasia |
3.3% |
| Decreased Appetite |
3.3% |
| Disease Progression |
3.3% |
| Erosive Duodenitis |
3.3% |
| Gastric Haemorrhage |
3.3% |
| Liver Disorder |
3.3% |
| Oedema |
3.3% |
| Partial Seizures |
3.3% |
| Skin Ulcer |
3.3% |
| Somnolence |
3.3% |
| Weight Decreased |
3.3% |
|
| Concomitant |
| Prophylaxis |
18.8% |
| Rheumatoid Arthritis |
15.9% |
| Chronic Hepatitis C |
6.8% |
| Cancer Pain |
6.3% |
| Hypertension |
5.3% |
| Product Used For Unknown Indication |
5.2% |
| Drug Use For Unknown Indication |
4.8% |
| Hepatitis C |
4.6% |
| Constipation |
4.1% |
| Colorectal Cancer |
3.5% |
| Gastritis |
3.2% |
| Osteoporosis |
3.2% |
| Pain |
3.1% |
| Stomatitis |
2.7% |
| Gastric Ulcer |
2.4% |
| Depression |
2.1% |
| Insomnia |
2.1% |
| Pneumonia |
2.1% |
| Herpes Zoster |
2.0% |
| Analgesic Therapy |
1.7% |
|
| White Blood Cell Count Decreased |
16.0% |
| Cerebral Haemorrhage |
7.4% |
| Interstitial Lung Disease |
7.4% |
| Upper Respiratory Tract Inflammation |
6.4% |
| Hepatic Function Abnormal |
5.3% |
| Neutrophil Count Decreased |
5.3% |
| Vasculitis Necrotising |
5.3% |
| Decreased Appetite |
4.3% |
| Diarrhoea |
4.3% |
| Fall |
4.3% |
| Pyrexia |
4.3% |
| Restlessness |
4.3% |
| Candida Pneumonia |
3.2% |
| Diabetes Mellitus |
3.2% |
| Disease Progression |
3.2% |
| Dysarthria |
3.2% |
| Herpes Zoster |
3.2% |
| Liver Disorder |
3.2% |
| Lower Gastrointestinal Haemorrhage |
3.2% |
| Malaise |
3.2% |
|
| Interacting |
| Acute Myocardial Infarction |
42.9% |
| Drug Use For Unknown Indication |
42.9% |
| Insomnia |
7.1% |
| Postoperative Analgesia |
7.1% |
|
| Drug Interaction Potentiation |
100.0% |
|
